#CapitalPolicy

Kubota Corporation will conduct a share buyback of up to 15 million shares (approximately 1.3% of total issued shares) with an upper limit of 30 billion yen, from April 22 to December 18, 2026, as a shareholder return measure.

As of March 31, 2026, the investment unit is set at 500,000 yen or more, and no reduction will be implemented at this time. However, the company intends to continue considering this matter in light of market trends and other factors.

Share buyback upper limit of 10,000,000 shares, total acquisition value of 50 billion yen, period from April 22, 2026 to March 31, 2027. Treasury stock cancellation is planned for 16,000,000 shares, resulting in an outstanding share count of 482,000,000 shares after cancellation.

On May 8, 2026, 160,000 shares of treasury stock will be disposed of by third-party allotment at 1,780 yen per share, totaling 284,800,000 yen, to fund the introduction of a stock compensation trust for executives.

On April 30, 2026, 65,529,800 shares (5.1% of the total issued shares) of treasury stock will be cancelled, resulting in a total of 1,223,217,590 shares outstanding after cancellation.

Ibiden Co., Ltd. implemented a stock split of one common share into two shares effective January 1, 2026, thereby reducing the trading unit.

On April 20, 2026, BuySell Technologies, Inc. issued 4,000 common shares as restricted stock compensation at 3,095 yen per share, completing payment totaling 12,380,000 yen.

The Company will be delisted from the Tokyo Stock Exchange Prime Market on April 21, 2026. The stock consolidation proposal was approved at the extraordinary shareholders meeting held on March 19, 2026.

5,820 new investment units issued by third-party allotment; total subscription amount JPY 661,722,360; payment due date April 22, 2026

The issue price for new share issuance is 1,635 yen per share, totaling approximately 6.77 billion yen. The share offering is 621,400 shares, totaling approximately 1.02 billion yen. Payment dates are April 24, 2026 and May 25, 2026.

Sumitomo Pharma will issue 51,304,400 new shares at 1,990 yen per share and also offer 7,695,600 shares at the same price. The total amount of funds to be raised is approximately 111.5 billion yen, with applications starting on April 21, 2026.

For the new share issuance, issue price is 710 yen, total amount 21.3 billion yen; share offering total approximately 43.7 billion yen; application period is from April 21 to 22, 2026